Quick Takeaways
- TANG CAPITAL MANAGEMENT LLC filed SCHEDULE 13G for Capricor Therapeutics, Inc. Common Stock, par value $0.001 per share (CAPR).
- Disclosed ownership: 6.6%.
- Date of event: 16 Jan 2026.
Quoteable Key Fact
"TANG CAPITAL MANAGEMENT LLC disclosed 6.6% ownership in Capricor Therapeutics, Inc. Common Stock, par value $0.001 per share (CAPR) on 16 Jan 2026."
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
See Original Filing| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| TANG CAPITAL MANAGEMENT, LLC | 6.6% | 3,399,900 | 0 | 3,399,900 | /s/ Kevin Tang | Manager | |
| KEVIN TANG | 6.6% | 3,399,900 | 0 | 3,399,900 | /s/ Kevin Tang | Self | |
| TANG CAPITAL PARTNERS, LP | 4.5% | 2,337,350 | 0 | 2,337,350 | /s/ Kevin Tang | Manager, Tang Capital Management, LLC, General Partner | |
| TANG CAPITAL PARTNERS INTERNATIONAL, LP | 2.1% | 1,062,550 | 0 | 1,062,550 | /s/ Kevin Tang | Manager, Tang Capital Management, LLC, General Partner | |
| TANG CAPITAL PARTNERS III, INC | 0% | 0 | 0 | 0 | /s/ Kevin Tang | Chief Executive Officer | |
| TANG CAPITAL PARTNERS IV, INC | 0% | 0 | 0 | 0 | /s/ Kevin Tang | Chief Executive Officer |